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Abstract 
In this research, a novel hybrid material bone implant manufacturing through the integration 
of two materials using additive manufacturing (AM) technology is proposed. Biomimetic 
application can manufacture high strength biomechanical implants with optimised geometry 
and mass. The combination of polymers allows a significant leap in the development and 
production of a great diversity of components and applications of biomaterials. A novel 
hybrid scaffold with a poly lactic acid (PLA) matrix reinforced with carbohydrate particles 
(cHA) is analysed using digital surface software in the mass proportions of 100/0, 95/5, 90/10 
and 80/20 for application in tissue and regenerative engineering, seeking a higher proposition 
strength of PLA. Filaments are used to fabricate scaffolds by 3D printing, using the fused 
deposition method. The frameworks are submitted to bioactivity tests, surface roughness 
evaluation, apparent porosity and mechanical analysis. Analysis of the microstructure of the 
composite particle evaluates the 3D surface luminance structure and the profile structure. 
Cross-sectional views of the specimens are extracted and analysed, and the surface 
roughness, waviness profile, and Gaussian filter of the structures are observed. In summary 
the structures are checked and analysed by SEM and EDS where possible, to observe the 
bioactive behaviour of the materials. The relationship between cHA content and roughness is 
shown to be proportional. The mechanical properties are shown to be affected by the reduced 
interaction between the PLA matrix and the cHA particles. 
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1. Introduction 
Findings from population statistical research institutes point to a rising life expectancy in the 
world population. As humans age, the risk of compromising organs, tissues and the body as a 
whole increases. Tissue engineering seeks to use biomaterials to replace conventional 
transplants. A biomaterial is defined as any substance or combination of materials, other than 
drugs or synthetic natural materials, which can be used, for any period, to partially substitute 
for any tissue, organ or function of the body for the purpose of maintaining or improving the 
lifespan of an individual [1]. A fundamental requirement of a biomaterial used in clinical 
medicine is that it is biocompatible, that is, it can coexist with human tissue without causing 
any undesirable or inappropriate effects [2, 3]. Biomaterials can be classified into three main 
categories: bioinert, intolerant materials that are not capable of inducing any biological 
interfacial bond between the implant and the host tissue [4, 5]; bioactive, capable of 
interacting with body tissues, forming chemical or biological bonds and favouring the 
development of processes such as implant fixation, colonisation and tissue regeneration; and 
bioreabsorbable, materials that are gradually reabsorbed until they disappear entirely and are 
wholly replaced by new tissue in vivo. In general, biomaterials can be classified into: natural, 
from plants and animals; and synthetic, which can be sub-categorised into metals, synthetic 
polymers, ceramics and composites [6, 7].  
Metal is a common materials used in the biomedical field for implants. Its high tensile 
strength and fatigue characteristics make it suitable for a variety of applications, such as 
dental implants, and joints such as knees and hips [8, 9]. However, metals have limitations 
related to corrosion, which can lead to toxicity or hypersensitivity reactions. Polymers are 
also widely used thanks to their full range of compositions, properties and shapes, in the form 
of matrixes, fibres, films and gels [10, 11]. Their processing possibilities enable the 
fabrication of complex forms and structures. If the final goal is to manufacture small 
components with complex geometry, understanding mechanical properties at a micro-scale is 
paramount [12, 13]. Traditional ceramics have high compressive strength but low tensile 
strength. Most ceramic materials are characterised by being hard and brittle, with a modulus 
of elasticity typically higher than that of bone. These characteristics stimulate the study of 
this class of material as a bone substitute, due to its easy confirmation and mechanical 
properties. Composite material is formed by the joining of elements, resulting in a new 
material with better properties [14, 15]. Composites have been increasingly studied over the 
years, because they have a high potential to generate combinations of features that cannot be 
obtained with conventional materials. This group of materials has recently come into use in 
the field of biomaterials, but has the possibility of being mechanically and biologically 
similar to human tissue.  
A particular classification of composites is organic-inorganic hybrid materials. These 
materials are formed by the combination of two or more organic and inorganic phases. In 
general, they are produced when there is a need for properties not found in materials with a 
single constituent [16]. They can have better mechanical, optical and thermal properties, 
combining the thermal and chemical stability of ceramic materials with the processability and 
flexibility of organic compounds and polymers. Advances in the development of biomaterials 
have been shown to be an essential tool for tissue engineering [17]. These materials can 
promote regenerative processes through the active transport of cellular populations and 
therapeutic agents, as well as providing structural support with similar mechanical properties 
to tissue [18]. Biomaterials should ideally degrade at a rate comparable to the growth of new 
tissues at the site of implantation. Synthetic biomaterials, such as calcium phosphate 
ceramics, hydroxyapatite (HAp) and carbonatite hydroxyapatite (cHA), are commonly used 
as osteoconductive bone graft materials. Carbonatite has carbonate groups replacing 
phosphate groups, but these materials, when used alone, have low tensile strength and a high 
susceptibility to fractures. Therefore, these materials generally serve as reinforcing filler for 
elements with a more elastic nature, such as PLA, which is a biodegradable and 
biocompatible polymer, widely used in biomedical and food engineering. The aim of this 
research is the production of poly (lactic acid) hybrids containing cHA, in various mass/mass 
proportions, by fused decomposition method (FDM). The purpose of the output frameworks 
is application in bone regeneration. The evaluation of bioactivity in the structures of pure 
PLA and various ratios of cHA and their mechanical behaviour is undertaken through 
compression tests. AccuCT microCT analysis software is used for automatic bone 
segmentation, in order to calculate morphometry parameters, including trabecular and cortical 
volumes, and calibrate the bone mineral density analysis. 
2. Materials 
2.1. Biomaterials for bone regeneration 
Biomaterials are widely used in tissue engineering for the regeneration of bone tissues. In this 
research, we present the results of a study of the biochemical properties of biomaterials and 
their role in cell growth. The focus of this work is the application of scaffolds made of a 
composite material, composed of poly (lactic acid) matrix reinforced with cHA particles. 
PLA is an aliphatic, thermoplastic, semi-crystalline or amorphous, biocompatible, 
biodegradable polyester, synthesised from lactic acid obtained from renewable sources [19,  
20]. Using FDM, 3D complex architectural scaffolds with various pore sizes and porosities can be 
generated by computer-controlled design, layer-by-layer printing and a solidifying process, as 
shown in Figure 1. The process involves the formation of bone with PLA/cHA with a fused 
deposition scaffold produced by 3D printing. Optical images illustrate the 3D periodic 
structure with a simple tetragonal symmetry showing integrity interfaces formed in layers and 
a radial structure comprised of alternating layers deposited in concentric fill patterns [21]. 
Figure 1 also shows an SEM section of 3D deposited scaffolds with homogeneous 1 mm fibre 




Figure 1.  The process of formation of bone with PLA/cHA by fused deposition, (a) two layer scaffold produced by 3D 
printing: optical images illustrating, (b) 3D periodic structure with a simple tetragonal symmetry showing integrity 
interfaces formed in layers, (c) 3D radial structure comprised of alternating layers deposited in concentric fill patterns, 
(d) SEM section of 3D deposited scaffolds with uniform 1 mm fibre spacing showing average fibre diameters and pore 
geometries at magnification of 20 
 
Poly (lactic acid) is a polymer produced by the polycondensation reaction or lactide ring 
opening. The fundamental constitutional unit of PLA is lactic acid. Lactic acid is an α-
hydroxy acid with an asymmetric carbon atom, with two optical isomers: L-lactic acid 
(PLLA) and D-lactic acid (PDLA). The L-isomer is produced in humans and other mammals, 
while the D and L enantiomers are produced in bacterial systems [21]. Lactic acid can be 
derived from renewable resources, such as ethanol or acetaldehyde, or from coal or oil. 
However, the vast majority of lactic acid produced today is obtained by bacterial 
fermentation of simple sugars. Table 1 shows the main properties of PLA and its polymer, 
being amorphous without a melting point as described by the manufacturer. 𝑇𝑔 is glass 
transition temperature and 𝑇𝑚 is melting temperature. 
 
Table 1. Mechanical and thermal properties of PLA 
Property Type of PLA biopolymer 
 PLA PLLA (Natureworks™ 4032D) PDLA (Natureworks™ 4031D) 
Density (g/cm3) 1.24 1.30 1.27 
Stress (MPa) 41 40 40 
Modulus of elasticity (GPa) 1.6 2.7 3.0 
Poisson ratio (%) 2.5 3.1 2.1 
𝑻𝒈 (
oC) 55.3 55 50 
𝑻𝒎 (
oC) 151.5 167.9 - 
 
PLA is a biodegradable polymer, and its main route of degradation is by cleavage of the ester 
linkages by hydrolysis, leading to a progressive reduction in molecular weight. This 
degradability, along with its biocompatibility, is the reason PLA has been widely used in the 
last four decades for medical applications, including suture and tissue engineering 
frameworks [22]. Hydroxyapatite, Ca10(PO4)6(OH)2, also known as HA or HAp, is a natural 
mineral constituent of bone, representing 30 to 70% of the mass of bones and teeth and with a 
Ca/P ratio of 1.67. Synthetic hydroxyapatite has the combined properties of bioactivity and 
biocompatibility with the human body and can promote bone growth thanks to its excellent 
biological response. These properties, combined with their high capacity to adsorb and absorb 
molecules, make hydroxyapatite excellent support for the long-acting anticancer drugs used 
in the treatment of bone tumours. The structure of hydroxyapatite allows isomorphic cationic 
and anionic substitutions with great ease. Ca2+ can be replaced by metals such as Pb2+, 
Cd2+, Cu2+, Zn2+, Sr2+, Co2+, Fe2+ etc., the phosphate groups by carbonates and 
vanadates, and hydroxyls by carbonates, fluorine and chlorine [23]. These substitutions may 
alter crystallinity, network parameters, crystal size, surface texture, stability and solubility of 
the hydroxyapatite structure. The characteristic of HAp, at the level of its structure, which 
allows numerous ion or ionic group substitutions, can be changed. Such changes generate a 
series of perturbations in the crystalline structure, which causes the crystallinity to decrease, 
while increasing its capacity for reabsorption in a physiological medium. The substitutions 
that are generally used are carbonate ions, in a concentration of 4-8% by weight in natural 
bone [24]. Figure 2 shows an SEM image of the PLA/cHA scaffold framework pores at a 






Figure 2. SEM image of the PLA/cHA scaffold framework pores at (a) 100/0, (b) 95/5, (c) 90/10, and (d) 80/20 
ratios 
 
Changing the structure of HAp results in cHA, which has the same physicochemical 
properties as HAp. It can improve the kinetics of absorption, making it faster, and improve 
the mechanical properties, making it a biomaterial increasingly similar to natural bone. 
Different types of cHA can be obtained depending on the site occupied by (CO3)2- replacing 
either (OH)- or (PO4)3-, called type A and type B substitution [25]. Type A is prepared at 
high temperature (1000 °C), and type B at lower temperature. The preparation method 
influences the kind of substitution generated. The two types of replacement have opposite 
effects on the network parameters. Type A change, in which the largest planar group of 
(CO3)2- replaces the (OH)- group, causes expansion in the a-axis and contraction in the 
dimensions of the c-axis [26]. Meanwhile, substitution of type B, in which a small plane 
group of (CO3)2- replaces the largest tetramer group of (PO4)3-, causes a contraction in the a-
axis and expansion in the dimensions of the c-axis. In a previous study [27], the presence of 
type B substitutions is shown to cause a decrease in crystallinity and an increase in solubility 
both in vitro and in vivo. The surface of A-cHA is shown to have a lower affinity for the 
human trabecular osteoblastic cell, compared to HA. In another study [25], the compressive 
strength of porous bodies of cHA is shown to be twice as high as the resistance in analogous 
porous HA samples. Mechanical strength is, therefore, less critical for porous cHA structures. 
It is also shown that cHA implants have higher osteoconductive and bioabsorption properties 
than similar HA implants. 
 
3. Method 
The composite used in this work consists of a matrix of poly (lactic acid) (PLA) with various 
levels of carbonated hydroxyapatite (cHA). PLA (Ingeo 2003D from NatureWorks) 
containing 4% DPLA isomer is common in the market. Carbonated hydroxyapatite is 
synthesised at 37°C, to have a particle diameter of less than 90 μm.  Table 2 shows the printer 
setting for fabricated scaffolds. 
 
Table 2. Printer settings for preparation of dumbbell-shaped specimens. 
Printer setting  Horizontal build direction Vertical build direction 
Nozzle diameter [mm] 0.4 0.4 
Perimeter shells 2 2 
Bottom solid layers 2 2 
Top, solid layers 2 2 
Layer height [mm] 0.15 0.15 
Infill [%] 99.9 99.9 
Infill pattern linear linear 
Head travel speed [mm/s] 100 120 
Print speed [mm/s] 50 70 
Nozzle temperature [oC] 200 195 
Platform temperature [oC] 65 65 
 
To produce a biomaterial with characteristics, such as mechanical strength, fracture 
toughness and rigidity, similar to human bone tissue, ceramic particles and nanoparticles, 
nano carbon tubes and HA particles/fibres are incorporated, as in the studies of many other 
researchers. Table 3 shows the mechanical properties of cortical (compact) and trabecular 
bones. 
 
Table 3 Mechanical behaviour of compact and trabecular bones after [28] 
 Strength (MPa) Modulus of elasticity (GPa) 
Compression Tension Twist 
Compact bone 100 - 230 78 - 150 50 - 150 7 - 30 
Trabecular bone 2 - 12 - - 0.05 - 0.5 
 
3.1. Bioactivity test and Chauvenet criterion 
The bioactivity was evaluated and reproduced in vitro using the biomimetic method, based on 
ISO 10993, in which the frameworks were immersed in a solution known as synthetic body 
fluid (SBF), which mimics body fluid, containing the ions present in blood plasma. When the 
ions in this solution are supersaturated, it is possible to observe the deposition of a layer on 
the surface of the scaffold with varying morphology. Triplicates of PLA/cHA frameworks 
were used in the mass/mass ratios of 100/0, 95/5, 90/10 and 80/20. The samples were 
immersed in FBS solution and placed in an oven at 37°C for 14 and 21 days, then the analysis 
of the chemical composition of the surface and its morphology were carried out [24]. In order 
to eliminate the discordant data obtained, further analysis was carried out with digital surface 
software. The Chauvenet criterion was used to determine which values should be excluded. 
This criterion eliminates a measure if: 
𝑑𝑗 = |(𝑦𝑗 − 𝑦)| > 𝑑𝑐ℎ (1) 
where 𝑑𝑐ℎis the Chauvenet rejection limit, defined by: 











where 𝐺(𝜂) is the Gaussian filter function. In this criterion a measured value can be rejected 
if the probability 𝑚 of obtaining the deviation from the mean is less than 
1
2𝑛
, where 𝑛 is the 
number of measurements. 
 
3.2. X-ray dispersive energy spectroscopy (EDS) 
In this analysis, the chemical elements present in the frameworks were identified using 
Quantax 70 Brucker equipment. A comparison was made between the Ca and P peaks present 
in the scaffolds with various concentrations of cHA. The analysed frameworks were 
submitted to the bioactivity assay for 0, 14 and 21 days in order to verify the variation in the 
intensity of the calcium and phosphorus peaks. X-ray diffraction was used to evaluate 
calcium phosphate deposition in 80/20 PLA/cHA frameworks after 21 days of bioactivity 
assay. PLA/cHA 100/0 and 80/20 frames were not submitted to the test and carbonatites were 
characterised for comparative purposes. The characterisations were performed using a 
Shimadzu XDR-6000 diffractometer, operated in a scanning range of 2 degree from 5 degree 
to 80 degree, in continuous scanning, with a scan speed of 2 degree/min. 
 
3.3. Mechanical and surface roughness 
Surface roughness is defined as the sum of the third and fifth order shape differences, 
overlapping and composing a material’s profile [29]. In this test, Taylor Hobson's dosimeter 
was used with a 2 μm radius probe. The parameter evaluated was the roughness average, 
denominated as 𝑅𝑎 (roughness average), which is a measure of the depth of roughness. 𝑅𝑎 is 
defined as the arithmetic mean deviation of the absolute values of the spacing ordinates (𝑦𝑖) 
of the roughness profile points about the midline, within the measurement path (μm) [30]. 
Scaffolds produced with mass/mass ratios of 100/0, 95/5, 90/10 and 80/20 were analysed. For 
each composition, three scaffolds were used, and measurements taken of three different 
filaments, both along the x-axis and the y-axis. Data were taken for a 3 mm extended surface 
located in the central region of each thread. To remove the discrepant values of 𝑅𝑎, the 
Chauvenet criterion was used. 
 
4. Results and discussion 
The surface roughness is presented in Figure 3, which shows the profile roughness and 
waviness profile of the Gaussian filter, with a cut-off of 2.5 mm. The roughness or arithmetic 
mean deviation (𝑅𝑎) was analysed and the values presented in the figure are the averages of 





Figure 3. Average arithmetic roughness and waviness filter extracted from samples PLA/cHA with Gaussian 
filter 2.5 mm at (a) 100/0, (b) 95/5, (c) 90/10, and (d) 80/20 ratios 
 
Figure 4 shows an increase in surface roughness as the concentration of carbonatite increases. 
Considering standard deviation, we can say that the results for roughness lie in the same 
range of values. The high standard deviation indicates an irregularity between the filaments. 
Surface roughness is an important factor influencing the biological response to the 
biomaterial. The increase of this characteristic potentiates the mechanism of mechanical 
anchoring of particles, improving cell adhesion [29]. The roughness, together with the pores 
present in the framework, are responsible for mimicking the bone structure, allowing both 
osteoblast adhesion and local revascularisation. It is possible to observe the graphs with the 
roughness patterns of the tested frames. The relationship between the percentage of cHA and 
the roughness was found to be proportional and affected by the poor interaction between the 
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Figure 4. Analysis of surface roughness profile along the x-axis for (a) 100/0, (b) 95/5, (c) 90/10, and (d) 80/20 
samples 
 
Compression tests were carried out on a universal testing machine (Instron 5567) using a 2 
kN load cell at a compression ratio of 1.3 mm/min. Data was taken every 0.1% of 
deformation. For each sample group of PLA/cHA 100/0, 95/5, 90/10 and 80/20, ten samples 
were used, 5 of which were analysed with the applied load on the XY plane and 5 with the 
applied load on the XZ plane as shown in Figure 1.  The sample sizes were measured with a 
digital calliper. The assay was performed using 𝑛 = 5, and the results for elasticity modulus 
and mechanical strength are presented as individual values and mean values, accompanied by 
the respective standard deviation. For a better analysis of these results, the Chauvenet 
criterion was used to discard distortive values, giving a more reliable average value [31]. The 
yield of the PLA/cHA composite material obtained was calculated. Each sample group was 
weighed before and after the process of incorporation of cHA into the PLA matrix. Table 4 
shows the values obtained. 
 
Table 4. Partial yield after material mixing 
Sample Initial mass (g) Mass after mixing (g) Yield (%) 
100/0-PLA/cHA 120.0 106.7 88.9 
95/5-PLA/cHA 119.99 113.2 94.6 
90/10-PLA/cHA 119.91 113.11 94.17 
80/20-PLA/cHA 120.23 110.90 92.23 
 
Analysing the returns of the mixtures, we can see the similarity between the yield values for 
all proportions, with all being observed as close to 90%, indicating a high yield for the 
technique used. 
 
4.1. Microstructural bioactivity characterisations 
The analysis of the bioactivity assay was monitored using scanning electron microscopy 
(SEM) and X-ray dispersive energy spectroscopy (EDS). From the information presented by 
these characterisations, the proportion of ideal carbohydrate for an excellent bioactive 
response was obtained in terms of the morphology and the composition of the surface of the 
scaffolds after the bioactive reaction. Figure 5 shows the spectra obtained by EDS and SEM 
for the PLA/cHA frameworks in the proportions 100/0, 95/5, 90/10 and 80/20 at the time of 






Figure 5. Spectrum and surface mapping of the scaffold in the ratios of (a) 100/0, (b) 95/5, (c) 90/10, and (d) 
80/20 
 
The micro-structural 3D printing view of the SEM composite of the scaffold frameworks at 
various ratios is shown in Figure 6. Analysing the data shown in Figure 6, referring to the 
cross-sections of the scaffolds, a relevant aspect is the deposition of two subsequent layers in 
the same direction, with each layer being approximately 0.3 mm thick. Possibly, such a layer 
deposition feature is related to the printing parameters, such as the height of the deposited 
layer. The FDM machine software responsible for calculation how many layers should be 
deposited in the same direction so that it reached the projected height. Since the projected 
height of each pore was 0.7 mm, the printer made a second deposition in the same direction 









Figure 6. Micro-structural 3D printing view of SEM composite of the scaffold frameworks at (a) 100/0, (b) 95/5, 
(c) 90/10, and (d) 80/20 ratios 
 
4.2. Mechanical compression test 
Figure 7 shows the percentage deformation, with curves relative to test bodies subjected to 
compressive stresses on the XY plane of the frames. The lines of the graph represent before 




























































Figure 7. Compressive stress via deformation of PLA/CHA scaffolds in (a) 100/0, (b) 95/5, (c) 90/10, and (d) 
80/20 mass ratio  
 
Figure 7 shows the results of general stress against deformation of a scaffold subject to a 
compression test in 3 distinct stages. Based on the data shown in Figure 7, it is possible to see 
a fall in the modulus of elasticity after the addition of cHA. However, even if there is a drop 
in these values with low concentrations of carbonatite, as the percentage of cHA increases, 
the modulus of elasticity increases, surpassing the value found in scaffolds made with pure 
PLA. In none of the samples were the values close to those ideal for human bones, possibly 
due to the poor chemical interaction between the polymer matrix and the ceramic filler. 
As shown in Figure 8, the zooming factor of the microstructure was determined using a x4 
micrometer of angular profile 180GL at spatial frequency 0.111 to 0.138 mm-1, along with 
the resultant amplitude, dominant spatial frequency (DSF), and maximum amplitude (MA) 
for the four ratios. The tolerance limit scale-sensitive fractal analysis of the R2 coefficient of 
the specimens was 0.915, a good value of tolerance limit, for the 100/0 ratio, 0.715, a fragile 
































































Figure 8. Averaged power spectrum density (PSD) of the 3D printing view of the bone composite in luminance 
converted form, (a) amplitude 1308GL², DSF 0.0129mm-1 , MA 13724GL², (b) amplitude 1210GL², DSF 
0.0129mm-1 , MA 10295GL²,  (c) amplitude 901GL², DSF 0.013mm-1 , MA 9595GL², (d) amplitude 284GL², 
DSF 0.0129mm-1, MA 15532GL² 
 
Figure 8 shows that the values for compressive strength fall with the addition of cHA. 
However, all samples present values within the range 2 to 12 MPa, coinciding with the 
expected values for trabecular bones. The frameworks produced by composite materials 
loaded on the XZ plane present resistance values within the same range. However, when the 
results of the test specimens subject to loading on the XY plane are analysed, it is possible to 
see an increase in the resistance in the case of the scaffolds produced with a 90/10 PLA/cHA 
mass ratio, possibly due to the smaller presence of failures. These low values of resistance 
can be justified by the second deposition in the same direction, as shown in Figure 8. This 
dual deposition leads to misalignment, facilitating the separation between layers, and thus 
damaging the mechanical characteristics of the frameworks. Double-deposited frames in the 
same direction present lower values of compressive strength than those printed with only one 
layer in each direction.  
Conclusions 
One significant application of 3D printing is fabricating bone scaffolds for replacing injured 
tissue with biodegradable material with appropriate mechanical properties. The majority of 
3D printer inks used in bone or cartilage applications have an inherent stiffness. A balance 
between ingredients must be struck for the creation of an appropriate printable biomaterial. In 
this research, a composite biomaterial, composed of a PLA matrix reinforced with carbonated 
HA particles in proportions of 10/0, 95/5, 90/10 and 80/20 is tested for suitability as a 
replacement for bone tissue. The mechanical properties observed indicate a low interaction 
between PLA and cHA, since, in general, the moduli of elasticity and compressive strength of 
the scaffolds produced in proportions 95/5, 90/10 and 80/20 have lower values than those 
found in the pure polymer. This weak interaction in the composite generates defects which 
act as stress concentrators, reducing the mechanical strength of the framework. It can be 
concluded from the results shown in Figure 8, that the composite 80/20 is better than the 
others. Another aspect that may influence the mechanical properties is the double deposition 
of filaments which facilitates the detachment of the layers, causing the layers of the test body 
to peel off earlier than expected, reducing the modulus of elasticity and strength. It is shown 
that an increase in the proportion of carbonatite in the frameworks can be definitive for bone 
regeneration. However, a more significant interaction between the matrix and the composite 
load is necessary, to achieve mechanical aspects close to those found in bone tissue. Further 
study could be done into the printing parameters, evaluating the impact of changes on 
mechanical behaviour and the compatibilisation between PLA and cHA. Finally, 
reproducibility concerns, quality control issues and regulatory hurdles need to be addressed 
before 3D printed scaffold devices can reach medical markets. 
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